BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Leuzzi V, Rossi L, Gabucci C, Nardecchia F, Magnani M. Erythrocyte-mediated delivery of recombinant enzymes. J Inherit Metab Dis 2016;39:519-30. [PMID: 27026098 DOI: 10.1007/s10545-016-9926-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Lutz H, Hu S, Dinh P, Cheng K. Cells and cell derivatives as drug carriers for targeted delivery. Medicine in Drug Discovery 2019;3:100014. [DOI: 10.1016/j.medidd.2020.100014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 4.7] [Reference Citation Analysis]
2 Pierigè F, Bigini N, Rossi L, Magnani M. Reengineering red blood cells for cellular therapeutics and diagnostics: Biomedical applications of reengineered erythrocytes. WIREs Nanomed Nanobiotechnol 2017;9:e1454. [DOI: 10.1002/wnan.1454] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
3 Dean SN, Turner KB, Medintz IL, Walper SA. Targeting and delivery of therapeutic enzymes. Ther Deliv 2017;8:577-95. [PMID: 28633594 DOI: 10.4155/tde-2017-0020] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
4 Li Y, Raza F, Liu Y, Wei Y, Rong R, Zheng M, Yuan W, Su J, Qiu M, Li Y, Raza F, Liu Y, Wei Y, Rong R, Zheng M, Yuan W, Su J, Qiu M. Clinical progress and advanced research of red blood cells based drug delivery system. Biomaterials 2021;279:121202. [PMID: 34749072 DOI: 10.1016/j.biomaterials.2021.121202] [Reference Citation Analysis]
5 Bukara K, Jovanic S, Drvenica IT, Stancic A, Ilic V, Rabasovic MD, Pantelic D, Jelenkovic B, Bugarski B, Krmpot AJ. Mapping of hemoglobin in erythrocytes and erythrocyte ghosts using two photon excitation fluorescence microscopy. J Biomed Opt 2017;22:26003. [PMID: 28301654 DOI: 10.1117/1.JBO.22.2.026003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
6 Rossi L, Fraternale A, Bianchi M, Magnani M. Red Blood Cell Membrane Processing for Biomedical Applications. Front Physiol 2019;10:1070. [PMID: 31481901 DOI: 10.3389/fphys.2019.01070] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
7 Rossi L, Pierigè F, Aliano MP, Magnani M. Ongoing Developments and Clinical Progress in Drug-Loaded Red Blood Cell Technologies. BioDrugs 2020;34:265-72. [PMID: 32198632 DOI: 10.1007/s40259-020-00415-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
8 Rossi L, Pierigè F, Agostini M, Bigini N, Termopoli V, Cai Y, Zheng F, Zhan CG, Landry DW, Magnani M. Efficient Cocaine Degradation by Cocaine Esterase-Loaded Red Blood Cells. Front Physiol 2020;11:573492. [PMID: 33013487 DOI: 10.3389/fphys.2020.573492] [Reference Citation Analysis]
9 Sato W, Zajkowski T, Moser F, Adamala KP. Synthetic cells in biomedical applications. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021;:e1761. [PMID: 34725945 DOI: 10.1002/wnan.1761] [Reference Citation Analysis]
10 Vickerman BM, O'Banion CP, Tan X, Lawrence DS. Light-Controlled Release of Therapeutic Proteins from Red Blood Cells. ACS Cent Sci 2021;7:93-103. [PMID: 33532572 DOI: 10.1021/acscentsci.0c01151] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
11 Pascucci T, Rossi L, Colamartino M, Gabucci C, Carducci C, Valzania A, Sasso V, Bigini N, Pierigè F, Viscomi MT, Ventura R, Cabib S, Magnani M, Puglisi-allegra S, Leuzzi V. A new therapy prevents intellectual disability in mouse with phenylketonuria. Molecular Genetics and Metabolism 2018;124:39-49. [DOI: 10.1016/j.ymgme.2018.03.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
12 Glassman PM, Hood ED, Ferguson LT, Zhao Z, Siegel DL, Mitragotri S, Brenner JS, Muzykantov VR. Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers. Adv Drug Deliv Rev 2021;178:113992. [PMID: 34597748 DOI: 10.1016/j.addr.2021.113992] [Reference Citation Analysis]
13 Rossi L, Pierigè F, Antonelli A, Bigini N, Gabucci C, Peiretti E, Magnani M. Engineering erythrocytes for the modulation of drugs' and contrasting agents' pharmacokinetics and biodistribution. Adv Drug Deliv Rev 2016;106:73-87. [PMID: 27189231 DOI: 10.1016/j.addr.2016.05.008] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]